The Middle EAST Primary Osteoarthritis Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including an aging population, increasing prevalence of obesity, and rising awareness about osteoarthritis treatment options. The demand for innovative therapies and medical...